Literature DB >> 18848881

Application of dermal microdialysis for the evaluation of bioequivalence of a ketoprofen topical gel.

Ralph Nii Okai Tettey-Amlalo1, Isadore Kanfer, Michael F Skinner, Eva Benfeldt, Roger K Verbeeck.   

Abstract

The purpose was to investigate dermal microdialysis (DMD) for the assessment of the bioavailability of a ketoprofen topical gel formulation and to evaluate this technique as a tool for the determination of bioequivalence. Four microdialysis probes were inserted into the dermis on the volar aspect of the forearms of 18 human subjects and the probes were perfused with normal saline for 60 min. A ketoprofen (2.5%, m/m) gel formulation (50mg) was applied to the skin directly overlying the probes and samples were collected at 30 min intervals for 5h. With the probes still in place in the dermis each site was scanned by ultrasound to determine the implantation depth of these probes. Ketoprofen concentration in dialysates was determined by LC-MS/MS. The area under the curve obtained from the concentration-time profiles from pairs of application sites in each subject was evaluated in order to assess bioequivalence. Ninety percent confidence intervals were calculated using the two one-sided test procedure and limits of 80-125% based on log-transformed data were used as acceptance criteria to declare bioequivalence. The intra-subject variability was 10% between probes whereas inter-subject variability was 68% (n=18). Bioequivalence was confirmed with a power greater than 90%.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18848881     DOI: 10.1016/j.ejps.2008.09.002

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  12 in total

Review 1.  Bioequivalence for topical products--an update.

Authors:  Yogeeta Narkar
Journal:  Pharm Res       Date:  2010-09-22       Impact factor: 4.200

2.  Assessment of topical bioequivalence using dermal microdialysis and tape stripping methods.

Authors:  Tuba Incecayir; Ilbeyi Agabeyoglu; Ulver Derici; Sukru Sindel
Journal:  Pharm Res       Date:  2011-04-16       Impact factor: 4.200

Review 3.  Current challenges in bioequivalence, quality, and novel assessment technologies for topical products.

Authors:  Avraham Yacobi; Vinod P Shah; Edward D Bashaw; Eva Benfeldt; Barbara Davit; Derek Ganes; Tapash Ghosh; Isadore Kanfer; Gerald B Kasting; Lindsey Katz; Robert Lionberger; Guang Wei Lu; Howard I Maibach; Lynn K Pershing; Russell J Rackley; Andre Raw; Chinmay G Shukla; Kailas Thakker; Nathalie Wagner; Elizabeta Zovko; Majella E Lane
Journal:  Pharm Res       Date:  2014-01-07       Impact factor: 4.200

Review 4.  Pharmacokinetics-Based Approaches for Bioequivalence Evaluation of Topical Dermatological Drug Products.

Authors:  Sam G Raney; Thomas J Franz; Paul A Lehman; Robert Lionberger; Mei-Ling Chen
Journal:  Clin Pharmacokinet       Date:  2015-11       Impact factor: 6.447

Review 5.  Role of microdialysis in pharmacokinetics and pharmacodynamics: current status and future directions.

Authors:  Francine Johansson Azeredo; Teresa Dalla Costa; Hartmut Derendorf
Journal:  Clin Pharmacokinet       Date:  2014-03       Impact factor: 6.447

6.  Tissue distribution and dermal drug determination of indomethacin transdermal-absorption patches.

Authors:  Jingjing Ma; Ying Gao; Yinghua Sun; Dawei Ding; Qi Zhang; Bingjun Sun; Menglin Wang; Jin Sun; Zhonggui He
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

7.  Variability in Capsaicin-stimulated Calcitonin Gene-related Peptide Release from Human Dental Pulp.

Authors:  Lorel E Burns; Austin A Ramsey; Joshua J Emrick; Malvin N Janal; Jennifer L Gibbs
Journal:  J Endod       Date:  2016-02-19       Impact factor: 4.171

8.  Comparison of open-flow microperfusion and microdialysis methodologies when sampling topically applied fentanyl and benzoic acid in human dermis ex vivo.

Authors:  R Holmgaard; E Benfeldt; J B Nielsen; C Gatschelhofer; J A Sorensen; C Höfferer; M Bodenlenz; T R Pieber; F Sinner
Journal:  Pharm Res       Date:  2012-03-15       Impact factor: 4.200

9.  Convective transport of highly plasma protein bound drugs facilitates direct penetration into deep tissues after topical application.

Authors:  Yuri Dancik; Yuri G Anissimov; Owen G Jepps; Michael S Roberts
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

10.  Blockade of leukocyte haptokinesis and haptotaxis by ketoprofen, diclofenac and SC-560.

Authors:  Saulius Paskauskas; Audrius Parseliunas; Vachtang Kerkadze; Rainer Nobiling; Jan Schmidt; Eduard Ryschich
Journal:  BMC Immunol       Date:  2011-11-12       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.